Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.86 USD | +2.26% | +5.65% | +68.63% |
05-06 | Oppenheimer Upgrades Chemomab Therapeutics to Outperform | MT |
04-10 | Transcript : Chemomab Therapeutics Ltd. - Special Call |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+68.63% | 12.22M | |
+9.58% | 115B | |
+12.41% | 107B | |
-3.41% | 21.6B | |
-12.38% | 22.31B | |
-5.29% | 19.19B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B |
- Stock Market
- Equities
- CMMB Stock
- News Chemomab Therapeutics Ltd.
- Transcript : Chemomab Therapeutics Ltd., Q1 2023 Earnings Call, May 11, 2023